Akero Therapeutics(AKRO.US) Officer Sells US$117.02K in Common Stock

$Akero Therapeutics(AKRO.US)$ Officer Young Jonathan sold 5,000 shares of common stock on Jul 1, 2024 at an average price of $23.404 for a total value of $117.02K.Source: Announcement What is statemen

Futu NewsJul 3 07:38

Form 144 | Akero Therapeutics(AKRO.US) Officer Proposes to Sell 351.9K in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 1, $Akero Therapeutics(AKRO.US)$ Officer Jonathan Young intends to sell 15,000 shares of its common stock on Jul 1, with a total market value of approximately $351.9K. Jo

Futu NewsJul 2 04:10

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero Therapeutics

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

PR NewswireJun 13 23:25

Cantor Fitzgerald Reiterates Overweight on Akero Therapeutics

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Akero Therapeutics (NASDAQ:AKRO) with a Overweight.

BenzingaJun 13 00:09

CCORF Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $56

CCORF analyst Edward Nash maintains $Akero Therapeutics(AKRO.US)$ with a buy rating, and maintains the target price at $56.According to TipRanks data, the analyst has a success rate of 40.9% and a tot

Futu NewsJun 12 20:33 · Ratings

Morgan Stanley Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $46

Morgan Stanley analyst Michael Ulz maintains $Akero Therapeutics(AKRO.US)$ with a buy rating, and maintains the target price at $46.According to TipRanks data, the analyst has a success rate of 40.8%

Futu NewsJun 12 07:31 · Ratings